CHRS - Coherus BioSciences, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Mar 2019)Next Qtr. (Jun 2019)Current Year (2019)Next Year (2020)
No. of Analysts2255
Avg. Estimate-0.9-0.65-2.11-0.51
Low Estimate-0.98-0.83-2.91-1.75
High Estimate-0.82-0.46-1.380.51
Year Ago EPS-0.74-0.68-3.22-2.11
Revenue EstimateCurrent Qtr. (Mar 2019)Next Qtr. (Jun 2019)Current Year (2019)Next Year (2020)
No. of Analysts1144
Avg. Estimate2.8M6.2M84.4M201.76M
Low Estimate2.8M6.2M62.3M150M
High Estimate2.8M6.2M127.31M262.25M
Year Ago SalesN/AN/AN/A84.4M
Sales Growth (year/est)N/AN/AN/A139.10%
Earnings History3/30/20186/29/20189/29/201812/30/2018
EPS Est.-0.7-0.64-0.77-0.86
EPS Actual-0.74-0.68-0.87-0.92
Difference-0.04-0.04-0.1-0.06
Surprise %-5.70%-6.30%-13.00%-7.00%
EPS TrendCurrent Qtr. (Mar 2019)Next Qtr. (Jun 2019)Current Year (2019)Next Year (2020)
Current Estimate-0.9-0.65-2.11-0.51
7 Days Ago-0.9-0.65-2.11-0.51
30 Days Ago00-1.270.25
60 Days Ago00-1.270.25
90 Days Ago00-1.270.25
EPS RevisionsCurrent Qtr. (Mar 2019)Next Qtr. (Jun 2019)Current Year (2019)Next Year (2020)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/A11
Growth EstimatesCHRSIndustrySectorS&P 500
Current Qtr.-21.60%N/AN/A-0.01
Next Qtr.4.40%N/AN/A0.05
Current Year34.50%N/AN/A0.05
Next Year75.80%N/AN/A0.11
Next 5 Years (per annum)23.00%N/AN/A0.10
Past 5 Years (per annum)N/AN/AN/AN/A